Carl D Regillo

Summary

Publications

  1. doi request reprint A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact
    Omesh P Gupta
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19140, USA
    Ophthalmology 117:2134-40. 2010
  2. doi request reprint Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
    Carl D Regillo
    Retina Service, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Am J Ophthalmol 145:239-248. 2008
  3. doi request reprint Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors
    Justis P Ehlers
    Wills Eye Institute, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 41:182-9. 2010
  4. doi request reprint Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors
    Alok S Bansal
    The Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:2364-70. 2012
  5. doi request reprint Removal of posterior segment retained lens material using the OZil phacoemulsification handpiece versus Fragmatome during pars plana vitrectomy
    Allen Chiang
    Mid Atlantic Retina, Retina Service of Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Retina 32:2119-26. 2012
  6. doi request reprint Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response
    Richard S Kaiser
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 43:13-9. 2012
  7. doi request reprint Short-term outcomes of 23-gauge pars plana vitrectomy
    Omesh P Gupta
    Retina Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 146:193-197. 2008
  8. ncbi request reprint Intravitreal bevacizumab (avastin) in central retinal vein occlusion
    Jason Hsu
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA
    Retina 27:1013-9. 2007
  9. ncbi request reprint Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration
    Justis P Ehlers
    Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 38:371-7. 2007
  10. doi request reprint Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact
    Gary Shienbaum
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 153:468-473.e1. 2012

Collaborators

Detail Information

Publications31

  1. doi request reprint A treat and extend regimen using ranibizumab for neovascular age-related macular degeneration clinical and economic impact
    Omesh P Gupta
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19140, USA
    Ophthalmology 117:2134-40. 2010
    ..To evaluate the visual outcome, number of injections, and direct medical cost of a "treat and extend" regimen (TER) in managing neovascular age-related macular degeneration (nAMD) with intravitreal ranibizumab...
  2. doi request reprint Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1
    Carl D Regillo
    Retina Service, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA
    Am J Ophthalmol 145:239-248. 2008
    ..To evaluate the efficacy and safety of ranibizumab administered monthly for three months and then quarterly in patients with subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD)...
  3. doi request reprint Ranibizumab for exudative age-related macular degeneration in eyes previously treated with alternative vascular endothelial growth factor inhibitors
    Justis P Ehlers
    Wills Eye Institute, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 41:182-9. 2010
    ..To evaluate ranibizumab for exudative age-related macular degeneration previously treated with pegaptanib, bevacizumab, or both...
  4. doi request reprint Optic neuropathy after vitrectomy for retinal detachment: clinical features and analysis of risk factors
    Alok S Bansal
    The Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmology 119:2364-70. 2012
    ..To describe the clinical characteristics of and risk factors for the development of optic neuropathy after pars plana vitrectomy (PPV) for macula-sparing primary rhegmatogenous retinal detachment (RRD) repair...
  5. doi request reprint Removal of posterior segment retained lens material using the OZil phacoemulsification handpiece versus Fragmatome during pars plana vitrectomy
    Allen Chiang
    Mid Atlantic Retina, Retina Service of Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Retina 32:2119-26. 2012
    ..To assess the utility of the torsional phacoemulsification handpiece compared to the Fragmatome during pars plana vitrectomy for removal of posterior segment retained lens material...
  6. doi request reprint Ranibizumab for eyes previously treated with pegaptanib or bevacizumab without clinical response
    Richard S Kaiser
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 43:13-9. 2012
    ..To assess the safety and efficacy of ranibizumab in patients who had inadequate response to pegaptanib or bevacizumab...
  7. doi request reprint Short-term outcomes of 23-gauge pars plana vitrectomy
    Omesh P Gupta
    Retina Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 146:193-197. 2008
    ..To report the initial experience and safety profile of 23-gauge pars plana vitrectomy (PPV) in eyes undergoing vitreoretinal surgery...
  8. ncbi request reprint Intravitreal bevacizumab (avastin) in central retinal vein occlusion
    Jason Hsu
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA
    Retina 27:1013-9. 2007
    ..To describe the effects of intravitreal bevacizumab in eyes with macular edema resulting from central retinal vein occlusions (CRVO)...
  9. ncbi request reprint Pegaptanib for choroidal neovascularization in treatment-naïve exudative age-related macular degeneration
    Justis P Ehlers
    Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Ophthalmic Surg Lasers Imaging 38:371-7. 2007
    ..To evaluate the use of intravitreal pegaptanib in the treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) in treatment-naive patients...
  10. doi request reprint Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact
    Gary Shienbaum
    Retina Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 153:468-473.e1. 2012
    ..To evaluate the visual outcomes, number of injections, and direct medical cost of a treat-and-extend regimen in managing neovascular age-related macular degeneration with intravitreal bevacizumab...
  11. doi request reprint Hypotony after 25-gauge vitrectomy using oblique versus direct cannula insertions in fluid-filled eyes
    Jason Hsu
    Retina Service, Wills Eye Institute, Philadelphia, Pennsylvania 19107, USA
    Retina 28:937-40. 2008
    ..To compare intraocular pressure (IOP) and rates of postoperative hypotony with 25-gauge pars plana vitrectomy (PPV) without tamponade using oblique versus direct cannula insertions...
  12. doi request reprint 23-Gauge transconjunctival pars plana vitrectomy for removal of retained lens fragments
    Paul S Baker
    Retina Service, Wills Eye Institute at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 152:624-7. 2011
    ..To examine the usefulness of 23-gauge pars plana vitrectomy (PPV) in removing retained lens fragments and to determine which cases require 20-gauge ultrasonic fragmentation...
  13. ncbi request reprint Postoperative complications associated with 25-gauge pars plana vitrectomy
    Omesh P I Gupta
    Retina Service, Wills Eye at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 38:270-5. 2007
    ..To report postoperative complications in eyes undergoing 25-gauge pars plana vitrectomy (PPV)...
  14. doi request reprint Association between high-risk disease loci and response to anti-vascular endothelial growth factor treatment for wet age-related macular degeneration
    Anton Orlin
    Scheie Eye Institute, Department of Ophthalmology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Retina 32:4-9. 2012
    ....
  15. ncbi request reprint Endophthalmitis after open globe injury: microbiologic spectrum and susceptibilities of isolates
    Sachin Chhabra
    Wills Eye Retina Service, Philadelphia, Pennsylvania 19107, USA
    Am J Ophthalmol 142:852-4. 2006
    ..To present the microbiologic spectrum and susceptibilities of isolates in posttraumatic endophthalmitis, and to provide a review of the literature...
  16. ncbi request reprint Clinical safety profile of posterior juxtascleral depot administration of anecortave acetate 15 mg suspension as primary therapy or adjunctive therapy with photodynamic therapy for treatment of wet age-related macular degeneration
    Carl D Regillo
    Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania 19107, USA
    Surv Ophthalmol 52:S70-8. 2007
    ....
  17. doi request reprint Preferred therapies for neovascular age-related macular degeneration
    Allen Chiang
    Retina Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, USA
    Curr Opin Ophthalmol 22:199-204. 2011
    ..This report reviews the current treatment strategies and ongoing clinical trials in the treatment of neovascular age-related macular degeneration (AMD)...
  18. doi request reprint Metallic intraocular foreign bodies: characteristics, interventions, and prognostic factors for visual outcome and globe survival
    Justis P Ehlers
    Wills Eye Institute, Philadelphia, Pennsylvania, USA
    Am J Ophthalmol 146:427-433. 2008
    ..To describe metallic intraocular foreign body (IOFB) injuries and identify prognostic factors for visual outcome and globe survival...
  19. doi request reprint Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma
    Alok S Bansal
    Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, 840 Walnut St, Ste 1440, Philadelphia, PA 19107, USA
    Arch Ophthalmol 130:1285-90. 2012
    ..To determine the long-term safety of pars plana vitrectomy (PPV) in eyes with plaque-irradiated posterior uveal melanoma...
  20. pmc Psychological and cognitive determinants of vision function in age-related macular degeneration
    Barry W Rovner
    Department of Psychiatry, Jefferson Medical College, Jefferson Hospital for Neuroscience, Philadelphia, Pennsylvania 19107, USA
    Arch Ophthalmol 129:885-90. 2011
    ....
  21. ncbi request reprint Evaluation of the potential acuity meter in predicting visual acuity after photodynamic therapy for choroidal neovascularization
    Bradley T Smith
    Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
    Ophthalmic Surg Lasers Imaging 37:6-11. 2006
    ..To evaluate the potential acuity meter in predicting visual acuity after photodynamic therapy of choroidal neovascular membranes caused by age-related macular degeneration...
  22. ncbi request reprint Photodynamic therapy in young patients
    Andrew Lam
    Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Ophthalmic Surg Lasers Imaging 37:182-9. 2006
    ..To present a consecutive case series of patients 50 years or younger who underwent photodynamic therapy (PDT) for choroidal neovascularization (CNV) from etiologies other than age-related macular degeneration...
  23. ncbi request reprint A review of treatments for macular degeneration: a synopsis of currently approved treatments and ongoing clinical trials
    Mimi Liu
    Retina Service, Wills Eye Hospital, Jefferson Medical College, Philadelphia, Pennsylvania, USA
    Curr Opin Ophthalmol 15:221-6. 2004
    ..The purpose of this report is to review recent literature and ongoing clinical trials of the treatment of neovascular age-related macular degeneration...
  24. doi request reprint Preferred therapies for neovascular age-related macular degeneration
    David R Lally
    Retina Service, Wills Eye Institute, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    Curr Opin Ophthalmol 23:182-8. 2012
    ..This report reviews the current treatment strategies and the most recent clinical trials in the treatment of neovascular age-related macular degeneration...
  25. ncbi request reprint Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years
    Bernard R Hurley
    The Retina Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 5109, USA
    Retina 26:S16-7. 2006
    ..To assess the number of laser burns applied to the peripheral retina to treat retinopathy of prematurity (ROP) in a recent population of patients and to compare that number with historical data...
  26. ncbi request reprint Macular exudative retinal detachment in a patient with a dural cavernous sinus fistula
    Sunir J Garg
    The Retina Service Wills Eye Hospital, Philadelphia, PA 19107, USA
    Arch Ophthalmol 124:1201-2. 2006
  27. ncbi request reprint Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection
    Mark L Nelson
    Retina Service, Wills Eye Hospital, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Retina 23:686-91. 2003
    ..To report potentially distinguishing characteristics between bacterial endophthalmitis and presumed noninfectious endophthalmitis associated with intravitreal triamcinolone acetonide injection...
  28. ncbi request reprint Intraoperative sclerotomy-related retinal breaks for macular surgery, 20- vs 25-gauge vitrectomy systems
    Richard Scartozzi
    Retina Service, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107, USA
    Am J Ophthalmol 143:155-6. 2007
    ..To compare the rate of intraoperative sclerotomy-related retinal breaks (SRRB) between 20- and 25-gauge vitrectomy systems for the correction of macular pucker (MP) and macular hole (MH)...
  29. ncbi request reprint Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients
    David M Brown
    Vitreoretinal Consultants, Houston, Texas 77030, USA
    Am J Ophthalmol 144:627-37. 2007
    ....
  30. doi request reprint Short-term outcomes of 25-gauge vitrectomy with silicone oil for repair of complicated retinal detachment
    Chirag P Shah
    From Wills Eye Institute, Philadelphia, Pennsylvania
    Retina 28:723-8. 2008
    ..To investigate the short-term outcomes of 25-gauge pars plana vitrectomy (PPV) in 18 cases of complicated retinal detachment requiring silicone oil tamponade...
  31. ncbi request reprint A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: part 1. Visual function and structural outcome
    Eugene Y J Ng
    University College of Dublin, National University of Ireland, Dublin, Ireland
    Ophthalmology 109:928-34; discussion 935. 2002
    ..To assess visual and structural outcomes after laser photocoagulation and transscleral cryotherapy for threshold retinopathy of prematurity (ROP) after 10 years...